Class information for:
Level 1: SECT HEPATOBILIARY SURG LIVER TRANSPLANTAT//AMINO ACIDS THERAPEUTIC USE//LIVER DISEASES COMPLICATIONS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
17371 539 33.9 65%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
261 18876 PROTEIN C//ACTIVATED PROTEIN C//TISSUE FACTOR

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SECT HEPATOBILIARY SURG LIVER TRANSPLANTAT Address 4 19% 3% 17
2 AMINO ACIDS THERAPEUTIC USE Author keyword 2 67% 0% 2
3 LIVER DISEASES COMPLICATIONS Author keyword 2 50% 1% 3
4 HEMOSTATIC ABNORMALITIES Author keyword 2 43% 1% 3
5 HEPATOSPLENIC SCHISTOSOMIASIS Author keyword 2 23% 1% 6
6 BLOOD COAGULATION DISORDERS ETIOLOGY THERAPY Author keyword 1 100% 0% 2
7 PROTAC R Author keyword 1 50% 0% 2
8 HYPERFIBRINOLYSIS Author keyword 1 13% 1% 8
9 HUME LEE TRANSPLANT Address 1 16% 1% 5
10 GASTROENTEROL 3 Address 1 23% 1% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 AMINO ACIDS THERAPEUTIC USE 2 67% 0% 2 Search AMINO+ACIDS+THERAPEUTIC+USE Search AMINO+ACIDS+THERAPEUTIC+USE
2 LIVER DISEASES COMPLICATIONS 2 50% 1% 3 Search LIVER+DISEASES+COMPLICATIONS Search LIVER+DISEASES+COMPLICATIONS
3 HEMOSTATIC ABNORMALITIES 2 43% 1% 3 Search HEMOSTATIC+ABNORMALITIES Search HEMOSTATIC+ABNORMALITIES
4 HEPATOSPLENIC SCHISTOSOMIASIS 2 23% 1% 6 Search HEPATOSPLENIC+SCHISTOSOMIASIS Search HEPATOSPLENIC+SCHISTOSOMIASIS
5 BLOOD COAGULATION DISORDERS ETIOLOGY THERAPY 1 100% 0% 2 Search BLOOD+COAGULATION+DISORDERS+ETIOLOGY+THERAPY Search BLOOD+COAGULATION+DISORDERS+ETIOLOGY+THERAPY
6 PROTAC R 1 50% 0% 2 Search PROTAC+R Search PROTAC+R
7 HYPERFIBRINOLYSIS 1 13% 1% 8 Search HYPERFIBRINOLYSIS Search HYPERFIBRINOLYSIS
8 ANTICOAGULATION PROTEINS 1 50% 0% 1 Search ANTICOAGULATION+PROTEINS Search ANTICOAGULATION+PROTEINS
9 AVATROMBOPAG 1 50% 0% 1 Search AVATROMBOPAG Search AVATROMBOPAG
10 BLOOD COAGULATION DISORDERS ETIOLOGY 1 50% 0% 1 Search BLOOD+COAGULATION+DISORDERS+ETIOLOGY Search BLOOD+COAGULATION+DISORDERS+ETIOLOGY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ACCELERATED FIBRINOLYSIS 48 91% 4% 20
2 INCREASED PLASMA FIBRINOLYSIS 22 68% 4% 19
3 CONVENTIONAL COAGULATION TESTS 11 48% 3% 16
4 DEFECTIVE AGGREGATION 5 63% 1% 5
5 CIRRHOSIS PATIENTS 4 31% 2% 11
6 ABNORMAL HEMOSTASIS TESTS 3 57% 1% 4
7 COMPENSATED FORM 3 100% 1% 3
8 HOSPITALIZED CIRRHOSIS PATIENTS 3 100% 1% 3
9 HYPERFIBRINOLYSIS 3 19% 3% 15
10 THROMBIN ACTIVATABLE FIBRINOLYSIS 2 14% 2% 12

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
MECHANISMS OF DISEASE The Coagulopathy of Chronic Liver Disease 2011 219 61 36%
The coagulation system in patients with end-stage liver disease 2015 2 31 39%
Deep vein thrombosis and pulmonary embolism in cirrhotic patients: Systematic review 2014 4 52 67%
Efficacy and safety of the use of heparin as thromboprophylaxis in patients with liver cirrhosis: A systematic review and meta-analysis 2013 6 15 73%
Hemostasis in Liver Disease: Implications of New Concepts for Perioperative Management 2014 8 99 30%
Abnormalities of hemostasis in chronic liver disease: Reappraisal of their clinical significance and need for clinical and laboratory research 2007 65 43 42%
Coagulopathy in liver diseases 2010 23 35 51%
Hypercoagulability in cirrhosis: causes and consequences 2011 65 96 36%
Established and new-generation antithrombotic drugs in patients with cirrhosis - Possibilities and caveats 2013 11 58 28%
Clinical utility of viscoelastic tests of coagulation in patients with liver disease 2013 9 104 31%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SECT HEPATOBILIARY SURG LIVER TRANSPLANTAT 4 19% 3.2% 17
2 HUME LEE TRANSPLANT 1 16% 0.9% 5
3 GASTROENTEROL 3 1 23% 0.6% 3
4 COURSE POLYCLIN THER Y 1 50% 0.2% 1
5 DIGEST HLTH EXCELLENCE GI HEPATOL 1 50% 0.2% 1
6 GASTROENTEROL GI SURG 1 50% 0.2% 1
7 GUVEN HOSP 1 50% 0.2% 1
8 HEMATOL ONCOLWARREN ALPERT MED 1 50% 0.2% 1
9 IRCCSMAGGIORE HOSP 1 50% 0.2% 1
10 LIVER UNITHEPAT HAEMODYNAM 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000196929 POSTREPERFUSION SYNDROME//POST REPERFUSION SYNDROME//VENO VENOUS BYPASS
2 0.0000174536 CLIN PATHOL BIOCHEM//ALPHA2 ANTIPLASMIN//TC 99M NC100668
3 0.0000121045 PORTAL VEIN THROMBOSIS//PORTAL BILIOPATHY//REX SHUNT
4 0.0000098347 DESMOPRESSIN//DDAVP//PHARMACOLOGY DESMOPRESSIN
5 0.0000089438 ACTIVATED PARTIAL THROMBOPLASTIN TIMES//BLUMEA RIPARIA//INTRATHECAL FIBRINOLYSIS
6 0.0000086750 THROMBIN GENERATION//SYN SE BV//PHYS BIOCHEM BLOOD
7 0.0000083768 TAFI//CARBOXYPEPTIDASE U//THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR
8 0.0000083481 RFVIIA//RECOMBINANT ACTIVATED FACTOR VII//RECOMBINANT FACTOR VIIA
9 0.0000080730 PERITONEOVENOUS SHUNT//DENVER SHUNT//MALIGNANT ASCITES
10 0.0000070915 PROTHROMBIN COMPLEX CONCENTRATE//PROTHROMBIN COMPLEX CONCENTRATES//ANTICOAGULATION REVERSAL